David Zaccardelli, President and CEO at Verona Pharma plc (VRNA), sold 520,664 shares at $1.67 ($838K) on 2022-11-01, disclosed to the SEC on 2022-11-03.
Open-market sale of $838k VRNA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.60 | 454,856 | $728K | 86.9% |
| 2 | $1.67 | 32,904 | $55K | 6.6% |
| 3 | $1.67 | 32,904 | $55K | 6.6% |
| Total | $1.61 avg | 520,664 | $838K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-29 | $7.1M | — | Filing → |
| VRNA | SELL | 2025-05-05 | $7.0M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $1.6M | — | Filing → |